Low-dose intradermal infection with Trypanosoma congolense leads to expansion of regulatory T cells and enhanced susceptibility to reinfection

Infection and Immunity

Volumn 82, Issue 3, 2014, Pages 1074-1083

  Onyilagha, Chukwunonso ^a   Okwor, Ifeoma ^a   Kuriakose, Shiby ^a   Singh, Rani ^a   Uzonna, Jude ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; CELLS, CULTURED; DISEASE SUSCEPTIBILITY; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; INTERFERON-GAMMA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKINS; LYMPH NODES; MICE; MICE, INBRED BALB C; PARASITEMIA; SPLEEN; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TRYPANOSOMA CONGOLENSE; TRYPANOSOMIASIS, AFRICAN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84894252626     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01028-13     Document Type: Article

References (54)

1. Simarro PP, Cecchi G, Paone M, Franco JR, Diarra A, Ruiz JA, Fevre EM, Courtin F, Mattioli RC, Jannin JG. 2010. The atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases. Int. J. Health Geogr. 9:57. http://dx.doi.org/10.1186 /1476-072X-9-57.
2. Stuart K, Brun R, Croft S, Fairlamb A, Gurtler RE, McKerrow J, Reed S, Tarleton R. 2008. Kinetoplastids: related protozoan pathogens, different diseases. J. Clin. Invest. 118:1301-1310. http://dx.doi.org/10.1172 /JCI33945.
3. Brun R, Don R, Jacobs RT, Wang MZ, Barrett MP. 2011. Development of novel drugs for human African trypanosomiasis. Future Microbiol. 6:677-691. http://dx.doi.org/10.2217/fmb.11.44.
4. Hursey BS. 2001. The programme against African trypanosomiasis: aims, objectives and achievements. Trends Parasitol. 17:2-3. http://dx.doi.org /10.1016/S1471-4922(00)01851-1.
5. Kristjanson PM, Swallow BM, Rowlands GJ, Kruska RL, de Leeuw PN.1999. Measuring the costs of African animal trypanosomosis: the potential benefits of control and returns to research. Agric. Syst. 59:79-98. http://dx .doi.org/10.1016/S0308-521X(98)00086-9.
6. Magez S, Truyens C, Merimi M, Radwanska M, Stijlemans B, Brouckaert P, Brombacher F, Pays E, De Baetselier P. 2004. P75 tumor necrosis factor-receptor shedding occurs as a protective host response during African trypanosomiasis. J. Infect. Dis. 189:527-539. http://dx.doi.org/10 .1086/381151.
7. Nakamura Y, Naessens J, Takata M, Taniguchi T, Sekikawa K, Gibson J, Iraqi F. 2003. Susceptibility of heat shock protein 70.1-deficient C57BL/6 J, wild-type C57BL/6J and A/J mice to Trypanosoma congolense infection. Parasitol. Res. 90:171-174. http://dx.doi.org/10.1007/s00436-003-0844-3.
8. Shi M, Wei G, Pan W, Tabel H. 2006. Experimental African trypanosomiasis: a subset of pathogenic, IFN-gamma-producing, MHC class IIrestricted CD4+ T cells mediates early mortality in highly susceptible mice. J. Immunol. 176:1724-1732.
9. Uzonna JE, Kaushik RS, Gordon JR, Tabel H. 1998. Immunoregulation in experimental murine Trypanosoma congolense infection: anti-IL-10 antibodies reverse trypanosome-mediated suppression of lymphocyte proliferation in vitro and moderately prolong the lifespan of genetically susceptible BALB/c mice. Parasite Immunol. 20:293-302.
10. Askonas BA. 1985. Macrophages as mediators of immunosuppression in murine African trypanosomiasis. Curr. Top. Microbiol. Immunol. 117: 119-127.
11. Roelants GE, Pinder M. 1984. Immunobiology of African trypanosomiasis. Contemp. Top. Immunobiol. 12:225-274.
12. Uzonna JE, Kaushik RS, Gordon JR, Tabel H. 1999. Cytokines and antibody responses during Trypanosoma congolense infections in two inbred mouse strains that differ in resistance. Parasite Immunol. 21:57-71. http://dx.doi.org/10.1046/j.1365-3024.1999.00202.x.
13. Tabel H, Kaushik RS, Uzonna JE. 2000. Susceptibility and resistance to Trypanosoma congolense infections. Microbes Infect. 2:1619-1629. http: //dx.doi.org/10.1016/S1286-4579(00)01318-6.
14. Jennings FW, Whitelaw DD, Holmes PH, Urquhart GM. 1978. The susceptibility of strains of mice to infection with Trypanosoma congolense. Res. Vet. Sci. 25:399-400.
15. Morrison WI, Murray M. 1979. Trypanosoma congolense: inheritance of susceptibility to infection in inbred strains of mice. Exp. Parasitol. 48:364-374. http://dx.doi.org/10.1016/0014-4894(79)90121-8.
16. Barry JD, Emergy DL. 1984. Parasite development and host responses during the establishment of Trypanosoma brucei infection transmitted by tsetse fly. Parasitology 88:67-84. http://dx.doi.org/10.1017/S0031182000054354.
17. Gray AR, Luckins AG. 1980. The initial stage of infection with cyclicallytransmitted Trypanosoma congolense in rabbits, calves and sheep. J. Comp. Pathol. 90:499-512. http://dx.doi.org/10.1016/0021-9975(80)90099-7.
18. Wei G, Bull Zhou HX, Tabel H. 2011. Intradermal infections of mice by low numbers of African trypanosomes are controlled by innate resistance but enhance susceptibility to reinfection. J. Infect. Dis. 203:418-429. http: //dx.doi.org/10.1093/infdis/jiq051.
19. Sakaguchi S. 2004. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22:531-562. http://dx.doi.org/10.1146/annurev.immunol .21.120601.141122.
20. Sakaguchi S, Setoguchi R, Yagi H, Nomura T. 2006. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in self-tolerance and autoimmune disease. Curr. Top. Microbiol. Immunol. 305:51-66. http: //dx.doi.org/10.1007/3-540-29714-6_3.
21. Sakaguchi S. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455-458. http://dx.doi.org/10.1016/S0092-8674(00)80856-9.
22. Sarfo BY, Wilson NO, Bond VC, Stiles JK. 2011. Plasmodium berghei ANKA infection increases Foxp3, IL-10 and IL-2 in CXCL-10 deficient C57BL/6 mice. Malar. J. 10:69. http://dx.doi.org/10.1186/1475-2875-10-69.
23. Okwor I, Liu D, Beverley SM, Uzonna JE. 2009. Inoculation of killed Leishmania major into immune mice rapidly disrupts immunity to a secondary challenge via IL-10-mediated process. Proc. Natl. Acad. Sci. U. S. A. 106:13951-13956. http://dx.doi.org/10.1073/pnas.0905184106.
24. Wei G, Tabel H. 2008. Regulatory T cells prevent control of experimental African trypanosomiasis. J. Immunol. 180:2514-2521.
25. Okwor I, Onyilagha C, Kuriakose S, Mou Z, Jia P, Uzonna JE. 2012. Regulatory T cells enhance susceptibility to experimental Trypanosoma congolense infection independent of mouse genetic background. PLoS Negl. Trop. Dis. 6:e1761. http://dx.doi.org/10.1371/journal.pntd.0001761.
26. Kuriakose S, Muleme HM, Onyilagha C, Singh R, Jia P, Uzonna JE.2012. Diminazene aceturate (Berenil) modulates the host cellular and inflammatory responses to Trypanosoma congolense infection. PLoS One 7:e48696. http://dx.doi.org/10.1371/journal.pone.0048696.
27. Tabel H. 1982. Activation of the alternative pathway of bovine complement by Trypanosoma congolense. Parasite Immunol. 4:329-335. http: //dx.doi.org/10.1111/j.1365-3024.1982.tb00444.x.
28. Lanham SM, Godfrey DG. 1970. Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose. Exp. Parasitol. 28: 521-534. http://dx.doi.org/10.1016/0014-4894(70)90120-7.
29. Herbert WJ, Lumsden WH. 1976. Trypanosoma brucei: a rapid "matching" method for estimating the host's parasitemia. Exp. Parasitol. 40:427-431. http://dx.doi.org/10.1016/0014-4894(76)90110-7.
30. Okwor I, Muleme H, Jia P, Uzonna JE. 2009. Altered proinflammatory cytokine production and enhanced resistance to Trypanosoma congolense infection in lymphotoxin beta-deficient mice. J. Infect. Dis. 200:361-369. http://dx.doi.org/10.1086/599792.
31. Morrison WI, Roelants GE, Mayor-Withey KS, Murray M. 1978. Susceptibility of inbred strains of mice to Trypanosoma congolense: correlation with changes in spleen lymphocyte populations. Clin. Exp. Immunol. 32:25-40.
32. Pereira de Almeida PJ, Ndao M, Goossens B, Osaer S. 1998. PCR primer evaluation for the detection of trypanosome DNA in naturally infected goats. Vet. Parasitol. 80:111-116. http://dx.doi.org/10.1016 /S0304-4017(98)00205-2.
33. Kaushik RS, Uzonna JE, Zhang Y, Gordon JR, Tabel H. 2000. Innate resistance to experimental African trypanosomiasis: differences in cytokine (TNF-alpha, IL-6, IL-10 and IL-12) production by bone marrowderived macrophages from resistant and susceptible mice. Cytokine 12: 1024-1034. http://dx.doi.org/10.1006/cyto.2000.0685.
34. Uzonna JE, Kaushik RS, Gordon JR, Tabel H. 1998. Experimental murine Trypanosoma congolense infections. I. Administration of anti-IFN-gamma antibodies alters trypanosome-susceptible mice to a resistant-like phenotype. J. Immunol. 161:5507-5515.
35. Uzonna JE, Kaushik RS, Zhang Y, Gordon JR, Tabel H. 1998. Experimental murine Trypanosoma congolense infections. II. Role of splenic adherent CD3+Thy1.2+ TCR-alpha beta-gamma delta-CD4+8-and CD3+Thy1.2+ TCR-alpha beta-gamma delta-CD4-8-cells in the production of IL-4, IL-10, and IFN-gamma and in trypanosome-elicited immunosuppression. J. Immunol. 161:6189-6197.
36. Sileghem M, Darji A, Hamers R, Van de Winkel M, De Baetselier P.1989. Dual role of macrophages in the suppression of interleukin 2 production and interleukin 2 receptor expression in trypanosomeinfected mice. Eur. J. Immunol. 19:829-835. http://dx.doi.org/10 .1002/eji.1830190508.
37. Sileghem M, Darji A, Remels L, Hamers R, De Baetselier P. 1989. Different mechanisms account for the suppression of interleukin 2 production and the suppression of interleukin 2 receptor expression in Trypanosoma brucei-infected mice. Eur. J. Immunol. 19:119-124. http: //dx.doi.org/10.1002/eji.1830190119.
38. Sileghem M, Flynn JN. 1992. Suppression of interleukin 2 secretion and interleukin 2 receptor expression during tsetse-transmitted trypanosomiasis in cattle. Eur. J. Immunol. 22:767-773. http://dx.doi.org/10.1002/eji .1830220321.
39. Sternberg J, McGuigan F. 1992. Nitric oxide mediates suppression of T cell responses in murine Trypanosoma brucei infection. Eur. J. Immunol. 22:2741-2744. http://dx.doi.org/10.1002/eji.1830221041.
40. Pearson TW, Roelants GE, Pinder M, Lundin LB, Mayor-Withey KS. 1979. Immune depression in trypanosome-infected mice. III. Suppressor cells. Eur. J. Immunol. 9:200-204. http://dx.doi.org/10.1002/eji.1830090306.
41. Kierszenbaum F, Muthukkumar S, Beltz LA, Sztein MB. 1991. Suppression by Trypanosoma brucei rhodesiense of the capacities of human T lymphocytes to express interleukin-2 receptors and proliferate after mitogenic stimulation. Infect. Immun. 59:3518-3522.
42. Borowy NK, Sternberg JM, Schreiber D, Nonnengasser C, Overath P.1990. Suppressive macrophages occurring in murine Trypanosoma brucei infection inhibit T-cell responses in vivo and in vitro. Parasite Immunol. 12:233-246. http://dx.doi.org/10.1111/j.1365-3024.1990.tb00951.x.
43. Murray PK, Jennings FW, Murray M, Urquhart GM. 1974. The nature of immunosuppression in Trypanosoma brucei infections in mice. II. The role of the T and B lymphocytes. Immunology 27:825-840.
44. Askonas BA, Corsini AC, Clayton CE, Ogilvie BM. 1979. Functional depletion of T-and B-memory cells and other lymphoid cell subpopulations during trypanosomiasis. Immunology 36:313-321.
45. Goodwin LG, Green DG, Guy MW, Voller A. 1972. Immunosuppression during trypanosomiasis. Br. J. Exp. Pathol. 53:40-43.
46. Hudson KM, Byner C, Freeman J, Terry RJ. 1976. Immunodepression, high IgM levels and evasion of the immune response in murine trypanosomiasis. Nature 264:256-258. http://dx.doi.org/10.1038/264256a0.
47. Sacks DL, Selkirk M, Ogilvie BM, Askonas BA. 1980. Intrinsic immunosuppressive activity of different trypanosome strains varies with parasite virulence. Nature 283:476-478. http://dx.doi.org/10.1038/283476a0.
48. Wellhausen SR, Mansfield JM. 1979. Lymphocyte function in experimental African trypanosomiasis. II. Splenic suppressor cell activity. J. Immunol. 122:818-824.
49. Grosskinsky CM, Askonas BA. 1981. Macrophages as primary target cells and mediators of immune dysfunction in African trypanosomiasis. Infect. Immun. 33:149-155.
50. Jayawardena AN, Waksman BH. 1977. Suppressor cells in experimentally trypanosomiasis. Nature 265:539-541. http://dx.doi.org/10.1038 /265539a0.
51. Schleifer KW, Mansfield JM. 1993. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins. J. Immunol. 151:5492-5503.
52. Tabel HWG, Bull H. 2012. Immunosuppression, induced upon intradermal infections, causes failures of vaccines against African trypanosomiases. Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. http://www.usask.ca/wcvm /departments/microbiology/African%20trypanosomiasis%20vaccine %20II%2015-9-2012.pdf
53. Campbell GH, Phillips SM. 1976. Adoptive transfer of variant-specific resistance to Trypanosoma rhodesiense with B lymphocytes and serum. Infect. Immun. 14:1144-1150.
54. Dempsey WL, Mansfield JM. 1983. Lymphocyte function in experimental African trypanosomiasis. V. Role of antibody and the mononuclear phagocyte system in variant-specific immunity. J. Immunol. 130:405-411.